%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Zsofia Kote-Jarai, Paul D. P. Pharoah, Nora Pashayan
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
www.plosmedicine.org
www.plosmedicine.org
endstream
endobj
3 0 obj
<>
endobj
4 0 obj
<>/XObject<>>>
endobj
6 0 obj
[15 0 R 16 0 R 17 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/A 18 0 R>>
endobj
18 0 obj
<>
endobj
16 0 obj
<>/Border[0 0 0]/A 19 0 R>>
endobj
19 0 obj
<>
endobj
17 0 obj
<>/Border[0 0 0]/A 20 0 R>>
endobj
20 0 obj
<>
endobj
7 0 obj
<>stream
x[ێ}߯CȆ8;}[Ȋ/
EV00f$")S]%;/ڝKOuuթSȳ(f3s5y>+r5M3\U)o[l힌|5l13S',_BaA|/Q*_>FB05{zdXПXkYWYUbsLͮn.gWygWˋ'žw>
IݝvK*˭5|YUb!?tlO^qIP?ׅ|q\jX/tmy?a?F ς4,C|]>(6n]-T^Uleݦ%]܆KöC}R;DV0uen UM,ۻ=YcoۡjkxM37/襴jE/~~)S\tJ 4Mޤ)3>m=ݳ>>ibAzCo)Ӻ0(/}u/v\)XPXf?lD9n?ƖjU^zzd"2uYakaÖnbpsSeeeTamb]W5E6j?u;wڰ
i|#Y61߰%Mii'a],NZ SP:Y L -dmV,0nn+/T.j>[g~O&u`nC2Q+w@Fot
H*٧'~߯׀mw81p&Q8w3``4t97Y_|:I-y?x=]DTƿc`
'0
dYvAd匾?=f-2̪^pʊ7_I 8XSٺ˛;J;s.6z{VT|[m
PꎃV9ٚ0J=_Tt+RzJBM#,D',4!y>l/NҙGΗOóejѝ'߰8#Sda9G(3RՕ jv,[90J&Pm:R:SfL0[+
B;;JkDs)3UGvmǾ]ج,s}\mg9/;ՓgC]wY{≞vA~|0Y\'zX&5VP 4RsȂnƹTW6~Ӯ6{.(S ݲuO7q7aXA%|0Qa7zQNq{